U.S., Sept. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07817641) titled 'Proton Therapy for Mediastinal Lymphoma (PROMLY)' on July 30.
Brief Summary: The study aims to investigate whether proton therapy is feasible in a national setting and whether proton therapy can reduce the risk of late toxicity (secondary cancers and heart toxicity) compared to foton therapy.
Study Start Date: May 01
Study Type: INTERVENTIONAL
Condition:
Mediastinal Lymphoma
Hodgkin Disease Lymphoma
Diffuse Large B Cell Lymphoma (DLBCL)
Intervention:
RADIATION: Proton therapy
If selected, patients will recieve protontherapy instead of photon therapy
Recruitment Status: RECRUITING
Sponsor: Rigshospitalet, Denmark
Informati...